Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia

Annals of the Rheumatic Diseases

Volumn 59, Issue 1, 2000, Pages 20-25

  Migliaresi, Sergio ^a   Tirri, Giuseppe ^a   Manzo, Ciro ^b   Bresciani, Alessandro ^a,b   Ambrosone, Lucia ^a   Spera, Marcantonio ^a,b   Barbarulo, Deborah ^b   Lombari, Vincenza ^b   Pirozzi, Giuseppe ^b   Borgia, Guglielmo ^c   Lombardi, Maria Luisa ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BLOTTING, WESTERN; CROSS-SECTIONAL STUDIES; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; SOLUBILITY;

EID: 0034069803     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.1.20     Document Type: Article

References (39)

1. 1 Martin P. Hepatitis C: more than just a liver disease. Gastroenterology 1993;104:320-3.
2. 2 Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123:615-20.
3. 3 McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.
4. 4 Ferri C, Greco F, Longobardo G, Palla P, Moretti A, Marzo E, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991;34:1606-10.
5. 5 Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biological and clinical significance of cryoglobulins. Am J Med 1974;57:775-88.
6. 6 Meltzer M, Franklin EC. Cryoglobulinemia: a study of 29 patients. Am J Med 1966;40: 828-36.
7. 7 Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and longterm follow-up of 40 patients. Am J Med 1980;69:287-308.
8. 8 Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P, et al. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988;79:20-5.
9. 9 Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
10. 10 Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:3047-53.
11. 11 Ferri C, Zignego AL, Bombardieri S, La Civita L, Longombardo G, Monti M, et al. Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas. Clin Exp Rheumatol 1995; 13 (suppl 13): 135-40.
12. 12 Zignego AL, Ferri C, Giannini C, La Civita L, Careccia G, Longombardo G, et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997;142:545-55.
13. 13 Ferrone S, Yamamura M, Grosse-Wilde H, Pouletty P. Summary of the serum-soluble HLA class I antigen component. In: Tsuji K, Aizawa M, Sasazuhi T, eds. HLA 1991. Proceedings 11th International Histocompatibility Workshop Conference. Oxford: Oxford Science Publications, 1992:1057-61
14. 14 Puppo F, Scudeletti M, Indiveri F, Ferrone S. Serum HLA Class I antigens: markers and modulators of an immune response? Immunol Today 1995;16:124-7.
15. 15 Puppo F, Picciotto A, Brenci S, Varagona G, Scudeletti M, Ghio M, et al. Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response? J Clin Immunol 1995;15:179-84.
16. 16 Hagihara M, Shimura T, Takebe K, Munkhbat B, Hosoi K, Kagawa T, et al. Serum concentration od soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol 1997;32:338-43.
17. 17 Alvarez-Cermeno JC, Echevarria JM, Lillar LM, Lazaro I, Bootello A, Gonzales-Porque P. Soluble class I antigens in serum and CSF of patients with varicella-zoster virus meningitis. J Neurol Neurosurg 1989;52:1194-6.
18. 18 Alvarez-Cermeno JC, Casado C, Villar LM, Ferreira A, Varela JM, Dominguez M, et al. Soluble class I antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neural Scand 1990;82:14-16.
19. 19 Puppo F, Brenci S, Lanza L, Bosco O, Imro MA, Scudeletti M, et al. Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. Hum Immunol 1994;40:259-66.
20. 20 Pickl WF, Majdic O, Fae I, Reuschel R, Holter W, Knapp W. The soluble pool of 2-free HLA class I -chains. Qualitative and quantitative characterization. J Immunol 1993;151: 2613-22.
21. 21 Bresciani A, Pirozzi G, Spera M, Lombardi ML, Ambrosone L, Migliaresi S, et al. Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity. Tissue Antigens 1998;52:44-50.
22. 22 Hausmann R, Zavazava N, Steinmann J, Muller-Ruchholtz W. Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin Exp Immunol 1993;91:183-8.
23. 23 Carbone E, Terrazzano G, Colonna M, Tuosto L, Piccolella E, Franksson L, et al. Natural killer clones recognize specific soluble HLA class I molecules. Eur J Immunol 1996;26:683-9.
24. 24 Zavazava N, Krönke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996;2:1005-10.
25. 25 Puppo F, Indiveri F, Scudeletti M, Ferrone S. Soluble HLA: new roles and uses. Immunol Today 1997;18:154-5.
26. 2-μ free HLA-B heavy chains. In: Tsuji K, Aizawa M, Sasazuki T, eds. Proceedings of the 11th International Histocompatibility Workshop and Conference. II. Oxford: Oxford University Press, 1992:393-5.
27. 27 Pellegrino MA, Ng AK, Russo C, Ferrone S. Heteregeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 1982;34:18-23.
28. 28 Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986;137:2299-306.
29. 29 Kao KJ, Scornik JC, Riley WJ, McQueen CF. Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol 1988;21:115-24.
30. 30 Sakaguchi K, Koide N, Takenami T, Matsushima H, Takabatake H, Ferrone S, et al. Soluble HLA class I antigens in sera of patients with chronic hepatitis. Gastroenterol Jpn 1992;27:206-11.
31. 31 Onji M, Kikuchi T, Kumon I, Masumoto T, Nadano S, Kajino K, et al. Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C. Hepatogastroenterology 1992;39: 340-3.
32. 32 Qian C, Camps J, Maluenda MD, Civeira MP, Prieto J. Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy. J Hepatol 1992;16:380-3.
33. 33 Gabrielli A, Manzin A, Candela M, Caniglia ML, Paolucci S, Danieli MG, et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin Exp Immunol 1994;97:87-93.
34. 34 de Maddalena C, Zehender G, Bianchi Bosisio A, Monti G, Monteverde A, Invernizzi F, et al. HCV-RNA detection using different PCR methods in sera, cryoglobulins and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 (suppl 13):119-22.
35. 35 Monteverde A, Ballarè M, Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 1997;19:99-110.
36. 36 Brieva JA, Villar LM, Leoro G, Alvarez-Cermeno JC, Roldan E, Gonzalez-Porqué P. Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma. Clin Exp Immunol 1990;82:390-5.
37. 37 Nocito M, Montalban C, Gonzalez-Porque P, Villar LM. Increased soluble serum HLA class I antigens in patients with lymphoma. Hum Immunol 1997;58:106-11.
38. 38 Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997;19:111-29.
39. 39 Zavazava N, Hausmann R, Muller-Ruchholtz W. Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA. Transplantation 1991;51:838-42.